Cypress Point Wealth Management, LLC C4 Therapeutics, Inc. Transaction History
Cypress Point Wealth Management, LLC
- $274 Million
- Q1 2025
Shares
2 transactions
Others Institutions Holding CCCC
# of Institutions
117Shares Held
63.1MCall Options Held
18.8KPut Options Held
0-
Lynx1 Capital Management LP San Juan, PR7.1MShares$10.6 Million4.2% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.98MShares$10.4 Million0.92% of portfolio
-
Orbimed Advisors LLC San Diego, CA6.83MShares$10.2 Million0.34% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT6.72MShares$10 Million0.06% of portfolio
-
Black Rock Inc. New York, NY4.55MShares$6.78 Million0.0% of portfolio
About C4 Therapeutics, Inc.
- Ticker CCCC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,913,800
- Market Cap $72.9M
- Description
- C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins for the treatment of cancer, neurodegenerative conditions, and other diseases. Its lead product candidate is CFT7455, an orally bioavailable MonoDAC degrader of protein that is in Phase 1/2 trial targeting ...